US-based Mopec has announced an expansion of its partnership with digital pathology technology provider Lumea.

The expanded alliance will see Mopec incorporate Lumea’s patented tissue-handling technology into its Maestro Encore Grossing Station to improve the accuracy of diagnostics and the efficiency of pathology lab operations.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The integration of Lumea’s technology into the Maestro Encore will be available as an add-on feature starting from 1 October 2025.

By 1 January 2026, the feature is set to become a standard component of the station, making it accessible to pathology labs across the globe.

Furthermore, Mopec will take on the role of exclusive distributor for Lumea’s consumable products.

These products, which are crucial in the pre-analytical phase of tissue handling, are designed to maintain tissue integrity, enhance yield, and contribute to patient diagnoses. They will be offered through Mopec’s distribution network.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The consumable products include the BxBoard, a device for collecting and transporting tissue samples that aims to replace the use of formaldehyde bottles, thereby streamlining the process for surgical and lab staff and enhancing the quality of tissue samples.

Another product, BxChip, is said to be a biomimetic organic polymer chip designed to hold needle-core biopsies in place, which helps in maintaining the orientation of the tissue and minimising the chance of tissue loss during diagnostic processes.

Mopec Group CEO Francis Dirksmeier said: “This next phase of our partnership with Lumea reinforces Mopec’s commitment to driving innovation that directly benefits patients and laboratory professionals.

“By integrating Lumea’s technology into the Maestro Encore, we are delivering a comprehensive solution that empowers laboratories to achieve greater accuracy, efficiency, and consistency in diagnosis.”

Headquartered in Michigan, US, Mopec provides equipment, technology, and services for anatomic and forensic pathology.

Lumea is known for its contributions to digital pathology, offering technology that enhances workflows, including a viewer that incorporates AI.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact